Granules Pharmaceuticals Inc. 2026-02-11 Health serious FDA
Health · FDA · Recall #FDA-D-0305-2026
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules… Recall
Issued February 11, 2026 · Granules Pharmaceuticals Inc.
In February 2026, Granules Pharmaceuticals Inc. recalled the Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Foreign Tablets/Capsules
What you should do
- 1 Stop using Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Granules Pharmaceuticals Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Granules Pharmaceuticals Inc.
- Category
- Health
- Recall date
- February 11, 2026
- Units affected
- Not reported
- Sold at
- US Nationwide.
- Recall number
- FDA-D-0305-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Granules Pharmaceuticals Inc. has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.